Kaplan-Meier estimates of stroke recurrent-free survival by cytoreductive drug. Patients on cytoreductive drugs (HU in 87%; n = 523) were compared with patients without cytoreductive agents (n = 28) during follow-up since the index event (median time on follow-up, 4.2 years; range, 0–11.9). P value from the log-rank test is reported.